Meera Hameed
About
Meera Hameed is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology.
According to data from OpenAlex, Meera Hameed has authored 214 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Pulmonary and Respiratory Medicine, 84 papers in Rheumatology and 60 papers in Oncology. Recurrent topics in Meera Hameed's work include Sarcoma Diagnosis and Treatment (100 papers), Bone Tumor Diagnosis and Treatments (52 papers) and Soft tissue tumor case studies (27 papers). Meera Hameed is often cited by papers focused on Sarcoma Diagnosis and Treatment (100 papers), Bone Tumor Diagnosis and Treatments (52 papers) and Soft tissue tumor case studies (27 papers). Meera Hameed collaborates with scholars based in United States, Japan and Canada. Meera Hameed's co-authors include Cristina R. Antonescu, Samuel Singer, Seena C. Aisner, Lu Wang, John H. Healey, Marc Ladanyi, Sinchun Hwang, Diana Mandelker, Murray F. Brennan and David S. Klimstra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Meera Hameed
208 papers receiving 6.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Meera Hameed United States | 42 | 3.3k | 2.1k | 1.9k | 1.5k | 917 | 214 | 7.0k | ||
| Akihiko Yoshida Japan | 42 | 3.7k 1.1× | 1.8k 0.9× | 1.4k 0.8× | 1.7k 1.1× | 854 0.9× | 279 | 6.0k | ||
| André M. Oliveira United States | 48 | 4.2k 1.3× | 2.0k 0.9× | 2.9k 1.5× | 1.3k 0.9× | 935 1.0× | 149 | 7.1k | ||
| Dolores López‐Terrada United States | 35 | 2.5k 0.7× | 1.7k 0.8× | 1.4k 0.7× | 1.5k 1.0× | 1.1k 1.2× | 142 | 5.3k | ||
| Sarah Dry United States | 47 | 2.3k 0.7× | 2.4k 1.1× | 1.7k 0.9× | 1.3k 0.8× | 850 0.9× | 197 | 7.2k | ||
| Narasimhan P. Agaram United States | 51 | 3.8k 1.1× | 2.4k 1.1× | 1.7k 0.9× | 1.2k 0.8× | 1.3k 1.4× | 109 | 6.4k | ||
| Wei‐Lien Wang United States | 40 | 3.7k 1.1× | 2.1k 1.0× | 2.4k 1.3× | 1.1k 0.7× | 1.1k 1.2× | 210 | 6.4k | ||
| Enrique de Álava Spain | 40 | 3.8k 1.2× | 1.9k 0.9× | 1.2k 0.6× | 2.7k 1.8× | 1.0k 1.1× | 186 | 6.9k | ||
| Leonard H. Wexler United States | 48 | 4.2k 1.3× | 2.2k 1.0× | 1.3k 0.7× | 1.3k 0.9× | 1.4k 1.6× | 159 | 7.6k | ||
| Khin Thway United Kingdom | 45 | 5.2k 1.6× | 2.9k 1.4× | 2.3k 1.2× | 1.5k 1.0× | 1.5k 1.6× | 276 | 8.0k | ||
| Takafumi Ueda Japan | 41 | 3.2k 1.0× | 1.8k 0.9× | 1.4k 0.7× | 1.3k 0.8× | 830 0.9× | 187 | 5.3k |
Countries citing papers authored by Meera Hameed
Since
Specialization
Citations
This map shows the geographic impact of Meera Hameed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meera Hameed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meera Hameed more than expected).
Fields of papers citing papers by Meera Hameed
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Meera Hameed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meera Hameed. The network helps show where Meera Hameed may publish in the future.
Co-authorship network of co-authors of Meera Hameed
This figure shows the co-authorship network connecting the top 25 collaborators of Meera Hameed. A scholar is included among the top collaborators of Meera Hameed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meera Hameed. Meera Hameed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bauer, Thomas W., Matthew G. Hanna, Kelly D. Smith, et al.. (2024). A multicenter study to evaluate the analytical precision by pathologists using the Aperio GT 450 DX. Journal of Pathology Informatics. 15. 100401–100401.
2.
Kerr, Darcy A., et al.. (2024). A potential conundrum in dermatopathology: molecularly confirmed superficial ossifying fibromyxoid tumors with unusual histomorphologic findings and a novel fusion. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(6). 1063–1073.
3.
Dermawan, Josephine K., Yanming Zhang, Chad Vanderbilt, et al.. (2024). Detection of GRM1 gene rearrangements in chondromyxoid fibroma: a comparison of fluorescence in‐situ hybridisation, RNA sequencing and immunohistochemical analysis. Histopathology. 85(6). 889–898.
4.
Mandelker, Diana, Antonio Marra, Nikita Mehta, et al.. (2023). Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. npj Precision Oncology. 7(1).
5.
Fujiwara, Tomohiro, Lingxin Zhang, Andrew Chandler, et al.. (2022). Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes. Human Pathology. 134. 30–44.
6.
Al‐Obaidy, Khaleel I., Julia A. Bridge, Liang Cheng, et al.. (2021). EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Modern Pathology. 34(10). 1921–1934.
7.
Hanna, Matthew G., Orly Ardon, Victor E. Reuter, et al.. (2021). Integrating digital pathology into clinical practice. Modern Pathology. 35(2). 152–164.
8.
Zhu, Guo, Daniel C. Ramirez, Wen Chen, et al.. (2020). Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma. Human Pathology. 104. 73–83.
9.
Doğan, Snjezana, Denise Frosina, Abhinita Mohanty, et al.. (2020). Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants. Human Pathology. 106. 45–53.
10.
Guan, Youxin, Kyung K. Peck, John K. Lyo, et al.. (2020). T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine. Radiology. 297(2). 382–389.
11.
Suehara, Yoshiyuki, Deepu Alex, Anita S. Bowman, et al.. (2019). Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations. Clinical Cancer Research. 25(21). 6346–6356.
12.
Gounder, Mrinal M., Guo Zhu, Eric Lis, et al.. (2019). Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy. Clinical Cancer Research. 25(7). 2064–2071.
13.
Khoury, Joseph D., Wei‐Lien Wang, Víctor G. Prieto, et al.. (2017). Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial. Clinical Cancer Research. 24(3). 521–531.
14.
Mathias, Melissa, Alexander J. Chou, Paul A. Meyers, et al.. (2016). Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement. Journal of Pediatric Hematology/Oncology. 38(5). e166–e168.
15.
Crago, Aimeé M., Brian T. Denton, Sébastien Salas, et al.. (2013). A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis. Annals of Surgery. 258(2). 347–353.
16.
Tafe, Laura J., Yelena Y. Janjigian, Michael Zaidinski, et al.. (2011). Human Epidermal Growth Factor Receptor 2 Testing in Gastroesophageal Cancer: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization. Archives of Pathology & Laboratory Medicine. 135(11). 1460–1465.
17.
Aisner, Seena C., Suzanne E. Dahlberg, Meera Hameed, et al.. (2010). Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study. Journal of Thoracic Oncology. 5(6). 885–892.
18.
Korah, Reju, et al.. (2006). Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Human Pathology. 38(1). 154–160.
19.
Tsai, James, Hana Aviv, Joseph Benevenia, et al.. (2004). HER-2/neu and p53 in Osteosarcoma: An Immunohistochemical and Fluorescence In Situ Hybridization Analysis. Cancer Investigation. 22(1). 16–24.
20.
Heller, Debra S., Meera Hameed, & Rebecca N. Baergen. (2003). Lack of proliferative activity of surface epithelial inclusion cysts of the ovary. International Journal of Gynecological Cancer. 13(3). 303–307.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Akihiko Yoshida Breakdown of academic impact, for papers by André M. Oliveira Breakdown of academic impact, for papers by Dolores López‐Terrada Breakdown of academic impact, for papers by Sarah Dry Breakdown of academic impact, for papers by Narasimhan P. Agaram Breakdown of academic impact, for papers by Wei‐Lien Wang Breakdown of academic impact, for papers by Enrique de Álava Breakdown of academic impact, for papers by Leonard H. Wexler Breakdown of academic impact, for papers by Khin Thway Breakdown of academic impact, for papers by Takafumi Ueda